Daily non-political popular news in brief.

UVa Health System team uncovers gene's role in type 1 diabetes

11-07-2007 · EurekAlert!

Researchers at the University of Virginia Health System have identified an enzyme thought to be an important instigator of the inner-body conflict that causes type 1 diabetes. A chronic condition that affects nearly three million American children and adults, type 1 diabetes is more severe than type 2.

Keywords: uva, health, system, team, uncovers, gene, role, type, diabetes, uncover, diabete

« Previous | Next »

Similar news on "UVa Health System team uncovers gene's role in type 1 diabetes":

UVa-led team uncovers important secret in gene replication
06-13-2007 · EurekAlert!
A team of researchers led by University of Virginia Health System geneticists has uncovered a major secret in the mystery of how the DNA helix replicates itself time after time. It turns out that it is not just the sequence of the bases -- building blocks -- in the DNA, but also how loosely or tightly the chromatin -- the material that makes up chromosomes -- is packed at different points of the chromosome that is critical.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Deficient regulators in the immune system responsible for type 1 diabetes
01-24-2008 · EurekAlert!
The reduction in the regulating capacity of some regulators of the immune system (called CD4+Treg cells,) seems to play a critical role in the onset of type 1 diabetes, as demonstrated in the latest study by Dr. Ciriaco Piccirillo, a researcher in the department of microbiology and immunology at the Research Institute of the McGill University Health Center and the principal investigator for this project. This study was published this month in the journal Diabetes.
Similar news · Read more »
Researchers uncover new piece to the puzzle of human height
01-13-2008 · EurekAlert!
In studies involving more than 35,000 people and a survey across the entire human genome, an international team supported in part by the National Institutes of Health has found evidence that common genetic variants recently linked to osteoarthritis may also play a minor role in human height. The findings were released today in the advance online publication of the journal Nature Genetics.
Similar news · Read more »
UVA reports surprising findings related to myotonic muscular dystrophy
12-17-2007 · EurekAlert!
New research from the University of Virginia Health System shows that, in cases of type 1 myotonic muscular dystrophy, a well known heart protein does several surprising things. The protein, NKX2-5, is a biomarker for heart stem cells. It is also very important for the normal development of the heart. The researchers were surprised to find that mice and individuals with DM1 actually overproduce NKX2-5, yet experience the same kind of heart problems associated with too little of it.
Similar news · Read more »
Genetic 'roadblock' hoped to inspire future type 2 diabetes research
10-02-2007 · EurekAlert!
A team of Mount Sinai Hospital researchers has found that a 'genetic roadblock' identified in a recent study could pave the way toward novel treatments for type 2 diabetes. In the study, researchers from the Samuel Lunenfeld Research Institute of Mount Sinai Hospital found the first genetic evidence that the elimination of the gene for glycogen synthase kinase-3 in mice sensitizes the animals to insulin.
Similar news · Read more »
UC Davis researchers discover novel pathway to increased inflammation in diabetes patients
11-27-2007 · EurekAlert!
Researchers at UC Davis Health System have discovered a novel pathway that results in increased inflammation of blood vessels in patients with type 1 diabetes.
Similar news · Read more »
Researchers identify a role for glucose-sensing neurons in type 2 diabetes
08-29-2007 · EurekAlert!
In cases of Type 2 diabetes, the body's cells fail to appropriately regulate blood glucose levels. Research led by scientists at Beth Israel Deaconess Medical Center and Oregon Health & Science University describes a previously unrecognized role for glucose-sensing neurons in the onset of the disease demonstrating that an important component of Type 2 diabetes may indeed be "in your head."
Similar news · Read more »
Unique role for blood formation gene identified
09-12-2007 · EurekAlert!
All blood cell production in adults depends on the steady work of a vital gene that if lost results in early bone marrow failure, Dartmouth Medical School cancer geneticists have found. Their research reveals an unexpected role for the gene in sustaining the adult blood-forming system, and opens novel strategies for targeting the gene, which is often involved in a type of childhood leukemia.
Similar news · Read more »
U of M-led study identifies new genetic risk factors for type 2 diabetes
04-26-2007 · EurekAlert!
Ten genetic variants associated with type 2 diabetes, a disease which impacts more than 170 million people worldwide, have been identified or confirmed by a US-Finnish team led by scientists at the University of Michigan School of Public Health.
Similar news · Read more »